| AUC | Area under the curve |
| AI | Artificial intelligence |
| BRAF | B-Raf proto-oncogene, serine/threonine kinase |
| CAF | Cancer-associated fibroblast |
| CITE-seq | Cellular indexing of transcriptomes and epitopes by sequencing |
| CD1a | Cluster of differentiation 1a |
| CD3 | Cluster of differentiation 3 |
| CD4 | Cluster of differentiation 4 |
| CD8 | Cluster of differentiation 8 |
| CD20 | Cluster of differentiation 20 |
| CD68 | Cluster of differentiation 68 |
| CD95 | Cluster of differentiation 95 |
| CE | Conformité Européenne |
| CODEX | Co-detection by indexing |
| cDC1 | Conventional type 1 dendritic cells |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| ctDNA | Circulating tumour DNA |
| CXCL10 | C-X-C motif chemokine ligand 10 |
| CXCL9 | C-X-C motif chemokine ligand 9 |
| CXCR3 | C-X-C motif chemokine receptor 3 |
| CycleGAN | Cycle-consistent generative adversarial network |
| DNA | Deoxyribonucleic acid |
| DSP | Digital spatial profiling |
| DSP-WTA | Digital spatial profiling whole transcriptome atlas |
| eTILs | Electronic tumour-infiltrating lymphocytes score |
| FOXP3 | Forkhead box P3 |
| GEP | Gene expression profile |
| GeoMx | GeoMx Digital Spatial Profiler platform |
| H&E | Haematoxylin and eosin |
| CD38^hi | High CD38 expression |
| HER2 | Human epidermal growth factor receptor 2 |
| IMC | Imaging mass cytometry |
| IMMUcan | Integrated Immunoprofiling of Large Adaptive Cancer Patient Cohorts |
| ICI | Immune checkpoint inhibitor |
| IHC | Immunohistochemistry |
| iNOS | Inducible nitric oxide synthase |
| IFN-γ | Interferon gamma |
| IFQuant | Immunofluorescence quantification software |
| IL-15 | Interleukin 15 |
| IL7R | Interleukin 7 receptor |
| KRAS | Kirsten rat sarcoma viral oncogene homologue |
| LAG-3 | Lymphocyte-activation gene 3 |
| LDH | Lactate dehydrogenase |
| MHC I | Major histocompatibility complex class I |
| mregDC | Mature regulatory dendritic cells |
| mRNA | Messenger ribonucleic acid |
| MDM | Monocyte-derived macrophage |
| MEK | Mitogen-activated protein kinase kinase |
| mIF | Multiplex immunofluorescence |
| MDSC | Myeloid-derived suppressor cell |
| NLR | Neutrophil-to-lymphocyte ratio |
| NSCLC | Non-small-cell lung cancer |
| OS | Overall survival |
| PD-1 | Programmed cell death protein 1 |
| PD-L1 | Programmed death-ligand 1 |
| PFS | Progression-free survival |
| QIF | Quantitative immunofluorescence |
| ROI | Region of interest |
| RNA | Ribonucleic acid |
| RNA-seq | RNA sequencing |
| Treg | Regulatory T-cell |
| S100B | S100 calcium-binding protein B |
| SOX10 | SRY-box transcription factor 10 |
| sPD-1 | Soluble programmed cell death protein 1 |
| sPD-L1 | Soluble programmed death-ligand 1 |
| TLS | Tertiary lymphoid structures |
| TCF4 | Transcription factor 4 |
| TCF7 | Transcription factor 7 |
| TGF-β | Transforming growth factor beta |
| TIICs | Tumour-infiltrating immune cells |
| TIL | Tumour-infiltrating lymphocyte |
| TME | Tumour microenvironment |
| TMB | Tumour mutational burden |
| WSI | Whole-slide imaging |